Tirzepatide Known by the brand names Mounjaro and Zepbound , tirzepatide is FDA-approved for type 2 diabetes and used off-label for weight loss
Peptides like this one are fragile molecules, and an injectable, subcutaneous form is generally the most predictable way to deliver a known, stable amount into the body
Retatrutide at the 12 mg dose produces approximately 28.7% body weight loss at 68 weeks, compared to 14.9% with semaglutide 2.4 mg at the same timepoint
Microdosing is a drug administration method involving significantly lower doses than are typically used for therapeutic effects
Reduced Fatigue Helps combat tiredness and alleviate symptoms of chronic fatigue
in Cell Metabolism note that SIRT1 activation improves mitochondrial efficiency and promotes a shift toward lipid utilization for energy, which can be especially beneficial in endurance and fat-loss settings (Price et al., Cell Metabolism )